Active Ingredient: DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Proprietary Name: NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;220MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207597
Product Number: 001
Approval Date: Jan 25, 2019
Applicant Holder Full Name: P AND L DEVELOPMENT LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information